News & Events

  • February 07, 2012

    Spherix Incorporated announced the closing of their Registered Direct offering in the amount of $1,150,001. EG&S acted as counsel to the placement agent.
     

  • February 06, 2012

    Jones Soda Co. announced the closing of their Registered Direct offering in the amount of $3,207,500. EG&S acted as counsel to the placement agent.
     

  • February 03, 2012

    Generex Biotechnology Corporation announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to Generex.
     

  • February 02, 2012

    Hyperdynamics Corporation announced the closing of their Registered Direct offering in the amount of $30,000,000. EG&S acted as counsel to the placement agent.
     

  • January 30, 2012

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $5,760,000.  EG&S acted as counsel to the placement agent.
     

  • January 20, 2012

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,700,000. EG&S acted as counsel to the placement agent.
     

  • January 18, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $870,000. EG&S acted as counsel to NutraCea.
     

  • January 17, 2012

    Barry Grossman gave a presentation on the requirements and methodologies used to Go Private and participated on a panel discussing Privatization of Chinese Companies.

    Click here to view the presentation

  • January 11, 2012

    Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions  (by number of transactions) for 2011.

    Click here to view the rankings

  • January 04, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2011.

    Click here to view the rankings

  • December 30, 2011

    AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000.  EG&S acted as counsel to the Investor.
     

  • December 27, 2011

    Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
     

  • December 21, 2011

    StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
     

  • December 13, 2011

    PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company,  announced the completion of their merger.  Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.

  • December 13, 2011

    Cell Therapeutics Inc. announced the closing of their registered direct in the amount of $20,000,000. EG&S acted as counsel to the Placement Agent.

  • December 07, 2011

    Capitol C Holdings LLC announced the completion of its refinancing of senior secured debt with NCB, FSB.  EG&S acted as counsel to Capitol C Holdings.

  • December 06, 2011

    Celsion Corporation announced the closing of their PIPE offering in the amount of $15,000,00.  EG&S acted as counsel to the Placement Agent.
     

  • November 23, 2011

    IceWEB, Inc. announced the closing of their private placement in the amount of $1,750,000.00. EG&S acted as counsel to the Placement Agent.
     

  • November 16, 2011

    Adventrx Pharmaceuticals, Inc. (AMEX: ANX) announced the completion of its underwritten public offering of common stock and warrants in the amount of $17,000,000.  EG&S acted as counsel to the underwriter.

  • November 16, 2011

    Bluff Point Associates Corp. announced the acquisition of a controlling interest in Connexin Software, Inc. of Connexin Software, Inc. for the amount of $6,375,000. EG&S acted as counsel to Bluff Point Associates Corp.

  • November 14, 2011

    InvestLink Technologies, LLC announced the sale of Interests to Aspire Financial Services, LLC. EG&S acted as counsel to the principals of InvestLink Technologies, LLC.
     

  • November 08, 2011

    Bluff Point Associates acquired majority ownership of fi360 Inc., a leading provider of educational training programs, professional designations and analytical and reporting technology for fiduciaries and financial service providers. EG&S acted as counsel to Bluff Point Associates.

  • November 08, 2011

    Thing Daemon, Inc., which owns and operates social media websites including theFancy.com, raised $10 million in private equity funding from a group of investors led by an affiliate of PPR, S.A. PPR is a global conglomerate of luxury brands including Gucci, Bottega Veneta and Yves Saint Laurent. EG&S acted as counsel to Thing Daemon.